New Search
If you are not happy with the results below please do another search
ENTERPRISE THERAPEUTICS
Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. The company is based in the UK with offices at the Sussex Innovation Centre.
Latest News
- Enterprise Therapeutics doses first subjects in Phase 1 trial for First-in-Class cystic fibrosis therapy ETD002August 17, 2020 - 9:00 am
- Enterprise Therapeutics appoints Dr David Morris MD as Chief Medical OfficerFebruary 10, 2020 - 9:00 am
- Enterprise Therapeutics publishes paper on novel therapeutic approach for treatment of all cystic fibrosis patientsJanuary 8, 2020 - 10:16 am
- TMEM16A Channel Function Does Not Influence Goblet Cell Numbers or Mucin Secretion In The Human Airway Epithelium – NACFC – Nashville – October 2019November 7, 2019 - 5:32 pm
Follow Us On Twitter
Enterprise Therapeutics doses first subjects in Phase 1 trial for first-in-class cystic fibrosis therapy
https://www.ddw-online.com/product-news/p323798-enterprise-therapeutics-doses-first-subjects-in-phase-1-trial-for-first-in-class-cystic-fibrosis-therapy.html
#CysticFibrosis
Contact Us
Sussex Innovation Centre,
University of Sussex,
Science Park Square,
Falmer, Brighton, BN1 9SB
info@enterprisetherapeutics.com
+44 (0)1273 234667
